Literature DB >> 16612125

Small for gestational age and the metabolic syndrome: which mechanism is suggested by epidemiological and clinical studies?

C Lévy-Marchal1, P Czernichow.   

Abstract

The metabolic and cardiovascular complications associated with in-utero undernutrition have been identified during the past 10 years. Reduced fetal growth is independently associated with an increased risk of development of cardiovascular diseases, the insulin-resistance syndrome or one of its components (i.e., hypertension, dyslipidaemia, impaired glucose tolerance and type 2 diabetes). Insulin resistance appears to be a key component underlying these metabolic complications. Although the mechanism remains unclear, several pieces of evidence support an active role of adipose tissue in the emergence of insulin resistance (an abnormal growth pattern and repartition, hypersensitivity to catecholamines, regulation of leptin and adiponectin secretion and modulation of peroxisome proliferator-activated receptor gamma). Among individuals born SGA, those who are more at risk of gaining excess adiposity are those who are thin at birth following a period of fetal growth restriction. This period of undernutrition is followed by a neonatal period of catch-up growth and renutrition. This pattern induces important modifications in adipose tissue, with long-term consequences, among which is a high risk of early development of insulin resistance. Not all individuals born SGA will show such modifications in adipose tissue, meaning that not all of those born SGA are at risk of insulin resistance and diabetes. From a broader point of view, several hypotheses have been proposed over the past 10 years to explain this unexpected association between being born SGA and the later development of disease. Each of them points to a detrimental fetal environment, to a genetic susceptibility or to interactions between these two components playing a critical role in this context. Although not confirmed, the hypothesis suggesting that this association could be the consequence of genetic/environmental interactions remains the most attractive. Copyright 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16612125     DOI: 10.1159/000091517

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  28 in total

1.  A meta-analysis of relationship between birth weight and cord blood leptin levels in newborns.

Authors:  Ru-Xiang Ren; Yi Shen
Journal:  World J Pediatr       Date:  2010-06-12       Impact factor: 2.764

2.  Adipose Tissue: A Metabolic Regulator. Potential Implications for the Metabolic Outcome of Subjects Born Small for Gestational Age (SGA).

Authors:  Arianna Maiorana; Chiara Del Bianco; Stefano Cianfarani
Journal:  Rev Diabet Stud       Date:  2007-11-10

Review 3.  Rate of neonatal weight gain and effects on adult metabolic health.

Authors:  Gerthe F Kerkhof; Anita C S Hokken-Koelega
Journal:  Nat Rev Endocrinol       Date:  2012-09-18       Impact factor: 43.330

4.  Pathways Linking Birth Weight and Insulin Sensitivity in Early Adolescence: A Double Mediation Analysis.

Authors:  Andraea Van Hulst; Gilles Paradis; Andrea Benedetti; Tracie A Barnett; Mélanie Henderson
Journal:  J Clin Endocrinol Metab       Date:  2018-12-01       Impact factor: 5.958

5.  Aortic intima-media thickness in nicotine-exposed rat pups during gestation and lactation period.

Authors:  Tamer Gunes; Mustafa Ali Akin; Ozlem Canoz; Dilek Coban; Bahar Ozcan; Mehmet Kose; M Adnan Ozturk; Selim Kurtoglu
Journal:  Eur J Pediatr       Date:  2011-03-01       Impact factor: 3.183

6.  Role of adiponectin and leptin on body development in infants during the first year of life.

Authors:  Elena Bozzola; Cristina Meazza; Marica Arvigo; Paola Travaglino; Sara Pagani; Mauro Stronati; Antonella Gasparoni; Carolina Bianco; Mauro Bozzola
Journal:  Ital J Pediatr       Date:  2010-03-18       Impact factor: 2.638

7.  The effect of fetal and neonatal nicotine exposure on renal development of AT(1) and AT(2) receptors.

Authors:  Caiping Mao; Jiawei Wu; Daliao Xiao; Juanxiu Lv; Yang Ding; Zhice Xu; Lubo Zhang
Journal:  Reprod Toxicol       Date:  2009-02-11       Impact factor: 3.143

8.  Is the metabolic syndrome a "small baby" syndrome?: the bogalusa heart study.

Authors:  Emily W Harville; Sathanur Srinivasan; Wei Chen; Gerald S Berenson
Journal:  Metab Syndr Relat Disord       Date:  2012-07-25       Impact factor: 1.894

9.  Perinatal nicotine exposure alters AT 1 and AT 2 receptor expression pattern in the brain of fetal and offspring rats.

Authors:  Caiping Mao; Hong Zhang; Daliao Xiao; Liyan Zhu; Yang Ding; Yuying Zhang; Lei Wu; Zhice Xu; Lubo Zhang
Journal:  Brain Res       Date:  2008-10-02       Impact factor: 3.252

10.  Characterization of the angiotensin (AT1b) receptor promoter and its regulation by glucocorticoids.

Authors:  Irina G Bogdarina; Peter J King; Adrian J L Clark
Journal:  J Mol Endocrinol       Date:  2009-05-01       Impact factor: 5.098

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.